Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. - Concepedia

Concepedia

Publication | Closed Access

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

392

Citations

13

References

1993

Year

Y. Shimada, Makoto Yoshino, A Wakui, I Nakao, K Futatsuki, Yasushi Sakata, M Kambe, Tetsuya Taguchi, N. Ogawa

Journal of Clinical Oncology

Abstract

CPT-11 showed promising antitumor activity against metastatic colorectal cancer that was resistant to prior therapy. Further clinical trials of combination chemotherapy using CPT-11 are justified.

References

	Year	Citations

Page 1